Tirzepatide Injections
Tirzepatide acts on GIP and GLP-1 receptors. Zepbound is approved for chronic weight management in eligible patients; Mounjaro is approved for type 2 diabetes. A clinician can review which indication, if any, applies to you.
Request a Consultation
Tirzepatide: Eligibility, Risks, and Follow-Up
Before considering a prescription, discuss your health history, other medicines, possible side effects, and weight management goals. Tirzepatide is used alongside nutrition and activity changes when prescribed for weight management. Some people are not candidates, and outcomes vary.
- Difference between Zepbound and Mounjaro
- Review of contraindications and side effects
- Nutrition and activity planning
- Dosing and follow-up questions
- Cost and insurance coverage discussion
Ask About Tirzepatide
Contact our office to discuss whether a medication consultation is appropriate for you.